Saba Capital Management »

Carmell Therapeutics Corp - US shares owned by Saba Capital Management

Quarter-by-quarter ownership of Carmell Therapeutics Corp - US (CTCXW) shares owned by Saba Capital Management from 13F filings

Historical chart of Saba Capital Management investment in Carmell Therapeutics Corp - US

Tip: Access up to 7 years of quarterly data

All positions including Carmell Therapeutics Corp - US held by Saba Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Carmell Therapeutics Corp - US by Saba Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.4k 20k 0.22
2023-09-30 $4.8k 20k 0.25

More positions owned by Saba Capital Management

Blackrock Esg Cap Allc Term Shs Ben Int (ECAT)
Blackrock Innovation And Grw Shs Ben Int (BIGZ)
Blackrock Health Sciences Te Com Shs (BMEZ)
Blackrock Capital Allocation Trust (BCAT)
Pimco Dynamic Income Strateg Com Shs Ben Int (PDX)
Adams Express Company (ADX)
ClearBridge Energy MLP Fund (EMO)
Nuveen CA Dividend Advantage Muni. Fund (NAC)
Clearbridge Mlp And Mids (CEM)
Hldgs Put Option (UAL)
Mainstay Cbre Global (MEGI)
Nuveen Nj Div Advantage Mun (NXJ)
Blackrock Calif Mun Income T Sh Ben Int (BFZ)
Blackrock Science & Technolo Shs Ben Int (BSTZ)
Charter Communications Inc N Cl A Put Option (CHTR)

View all positions for Saba Capital Management

Top funds holding Carmell Therapeutics Corp - US

Balyasny Asset Management
Millennium Management
OZ Management
Highbridge Capital Management
Exos TFP Holdings
CNH Partners
Walleye Trading Advisors
Cowen And Company
Flow Traders US
Saba Capital Management
Whitebox Advisors
Wolverine Asset Management
Ancora Advisors

View all funds holding Carmell Therapeutics Corp - US